Nine patients with severe mitral disease were studied before and six months after mitral valve replacement with a three-cusp stented prosthesis using fresh autologous fascia lata tissue. Only patients in whom there was no auscultatory and angiographic evidence of incompetence of the replaced valve were selected for restudy. All patients claimed a marked improvement in their exercise capacity after operation and there was a significant reduction in radiographic heart size. The cardiac output at rest and the response to exercise were both reduced before operation and were unchanged after valve replacement. The elevated pulmonary arterial and wedge pressures were significantly reduced after operation in all patients both at rest and during exercise, but in no instance were the postoperative exercise values within normal limits. Left ventricular end-diastolic pressure was within normal limits at rest and during exercise in all patients after valve replacement but the average pressure gradient across the fascia lata valve was 6 ± 1 mm Hg at rest and 18 ± 3 mm Hg during exercise. These findings indicate that although replacement of the diseased mitral valve with a competent fascia lata prosthesis afforded substantial symptomatic relief, reduction of cardiac enlargement and a lowering of the pulmonary vascular pressures, this artificial valve offered a significant obstruction to left ventricular diastolic filling, particularly during exercise.
THE MAJORITY of mechanical prostheses used in mitral valve replacement have serious clinical hemodynamic limitations; these include thrombus formation, poor hydraulic function, high inertial loading, mechanical interference with ventricular contraction, failure of the prosthesis and chronic hemolysis. Recent attention has, therefore, been directed to the use of prostheses using biological tissues. In order to simulate the functional architecture of the natural semilunar valves and thus allow unobstructed axial flow, the majority of these prostheses have been fashioned as a three-cusp structure supported on a plastic-coated rigid metal ring. The cusps have been constructed from a variety of pliant tissues, including aortic valve homografts,1-3 and pig4 and calf5 heterografts. However, the durability of many of these valves has been relatively short-lived and stronger tissues from which to construct the cusps have been sought. Senning' reported that aortic valves fashioned from fascia lata had survived over four years in patients without degeneration, calcification or thromboembolic complications. In view of the theoretical advantages of valves fashioned from the host's own tissues, this technique has recently been applied to the replacement of the mitral valve with a prosthesis constructed from the patient's own fascia lata.7-9 This report concerns an appraisal of the clinical and hemodynamic effects of mitral valve replacement with such prostheses in patients with severe rheumatic heart disease, with particular respect to the results in patients in whom the replaced valve was functionally competent.
Methods

Subjects
Nine patients, including five females, who had undergone mitral valve replacement with fascia lata grafts, were selected for reinvestigation from a larger group of surgically treated patients on the basis of having no auscultatory evidence of important incompetence of the mitral fascia lata valve during the six months immediately following operation. Clinical auscultatory findings were confirmed by phonocardiograms and left ventricular angiography. Pulmonary wedge and arterial pressures were measured through the distal and proximal lumens respectively of a double-lumen catheter (9F gauge; U.S. Catheter Co.). The pulmonary wedge pressure measurement was made by impacting the catheter in a peripheral site in the right lower lung. The criteria of "wedging" required to be satisfied in all instances were that the pressure contour was distinctly different and the phasic and mean pressures lower than those recorded simultaneously from the pulmonary artery, and that aspiration of the catheter drew either fully saturated blood or no blood. To ensure that the catheter tip was not end-impacted against the vessel wall, in which case it would give erroneously low measurements, saline in an open column was required to fall freely to the same level as the electrically transduced pressure when connected to the pulmonary wedge catheter.
Pulmonary and systemic vascular pressures were transduced with strain-gauge manometers (SEM 486), integrated electronically and recorded on an ultra-violet light recorder (SEM 3012). Left ventricular end-diastolic pressure was measured immediately before the onset of ventricular systole. Pressures were measured over two respiratory cycles during each minute and averaged over the same four minutes of rest and final two minutes of exercise as the cardiac output determination. In this laboratory, using such methods under similar conditions of study, measurements of oxygen uptake, cardiac output and intracardiac pressures have been found to be repeatable within 5%, 7% and 8%, respectively. The pressure gradient across the mitral fascia lata graft was measured from the pulmonary wedge -mean left ventricular end-diastolic pressure gradient. In thirty-six subjects without mitral valve disease studied under similar conditions in this laboratory, the mean mitral valve pressure gradient (PMW-LVED pressure difference) was 0.0 ± 1 mm Hg (SD = 2) both at rest and during supine bicycle exercise at similar work loads to those used in the present study; at this level of exercise and oxygen uptake the pulmonary wedge mean pressure did not exceed 20 mm Hg in any of the 36 subjects.
Left ventricular angiography was carried out through a pigtail multi-lumen catheter (110 cm; Cordis Europa N.V.) introduced percutaneously into a femoral artery with retrograde manipulation under radiographic screening control across the aortic valve.
The cardiothoracic ratio was measured from posteroanterior standing six-foot chest radiographs taken in full inspiration. The ratio was taken as the proportion of the thoracic width occupied by the maximum horizontal cardiac diameter.
The probability of statistical significance of differences was calculated by Student's t-test for paired data.
Results Clinical Changes after Mitral Valve Replacement
Before operation all patients had conspicuous clinical and angiographic evidence of severe mitral valve disease with predominant incompetence. All were severely disabled by breathlessness on exertion; none were able to walk more than a few hundred yards on the flat in equable weather or climb a flight of twelve stairs at a normal pace or do manual work without undue breathlessness. Although no patient was in congestive heart failure immediately before operation, three were orthopneic and two had suffered from attacks of nocturnal dyspnea in the months immediately preceding admission to hospital.
After operation none had a mitral pansystolic murmur but four of the nine patients had a short early systolic murmur audible at the left sternal border. All had an unmistakable mitral opening-snap and five had a distinct mid-diastolic murmur. None had any angiographic evidence of incompetence of the prosthesis. All nine patients claimed a significant improvement in their capacity to exercise; all stated that they could now walk more than a mile or climb a flight of stairs at a normal pace without undue breathlessness and all claimed they were able to undertake normal manual work. None suffered orthopnea or attacks of nocturnal breathlessness during the six months after operation.
Radiographic Changes after Mitral Valve Replacement
Before operation the average cardiothoracic ratio was 0.59 (range 0.54-0.63); six months after operation the average ratio was 0.54 (range 0.51-0.60) (P < 0.05).
Hemodynamic Changes after Mitral Valve Replacement
Changes at Rest ( fig. 1, table 1 ). There was a significant reduction in the postoperative resting pulmonary wedge and pulmonary arterial mean pressures compared with the preoperative measurements; other hemodynamic variables were not significantly changed.
At rest, after operation the left ventricular enddiastolic pressure was within normal limits in all patients. The average pulmonary wedge mean-left ventricular end-diastolic pressure gradient across the fascia lata valve was 6 ± 1 mm Hg compared with a mitral valve gradient of 0 ± 1 mm Hg measured under similar conditions in this laboratory in subjects without mitral valve disease (P < 0.001).
Changes during Exercise ( fig. 1, table 1 ). After operation, at the same level of exertion and oxygen uptake, there was a significant reduction in the pulmonary wedge and pulmonary arterial mean pressures compared with the preoperative measurements. But, in all patients, the pulmonary pressures during exercise exceeded normal limits (PAP < 30 mm Hg, PWP < 20 mm Hg at oxygen uptake < 400 ml/min/m2). There were no statistically significant changes in any of the other hemodynamic variables measured.
After valve replacement, the left ventricular enddiastolic pressure during exercise was within normal limits in all patients. The average pulmonary wedge mean-left ventricular end-diastolic pressure gradient across the fascia lata valve was 18 ± 3 mm Hg; this was significantly greater than the average resting gradient in these patients (P < 0.001) and significantly in excess of the mitral valve gradient of 0 + 1 mm Hg measured at similar levels of exercise in subjects without mitral valve disease.
Discussion
This study was concerned with the clinical and hemodynamic effectiveness of mitral valve replacement with autologous fascia lata valves in patients severely disabled by mitral valve disease and in whom the replaced valve was functionally competent. Patients satisfying these criteria all experienced a marked improvement in their capacity to exercise without undue breathlessness and all claimed they were able to perform normal physical activities after operation. The size of the heart was significantly reduced in all patients. There was no consistent change in cardiac output, heart rate or systemic arterial pressure, but there was a significant reduction in the pulmonary wedge and arterial pressures both at rest and during exercise in all patients. However, it must be emphasized that in all patients the postoperative pulmonary pressures continued to exceed upper normal limits, although the left ventricular end-diastolic pressure was within the normal range in all subjects both at rest and during exercise. Thus, although the largest possible diameter of prosthesis was used in each patient these findings indicate that the mitral fascia lata valve graft offered significant obstruction to blood flow. In this respect, it is of interest that all patients had an opening snap and a distinct mid-diastolic murmur was audible in five.
The relation of these hemodynamic findings, improved by operation but still quite abnormal, to the nearly complete relief of breathlessness claimed by these patients is worthy of further consideration. Despite their claims to the contrary, it is doubtful that these patients had a normal capacity to exercise, particularly in view of the residual high mitral valve pressure gradient and high pulmonary pressure even during mild exertion. In fact others have found that many patients who claim to be entirely well are quite unable to meet the ordinary daily requirements of physical activity. largely for the simplicity of construction. However, the originators of these valves appear to have ignored the dissimilar mechanical and hydraulic functions of the aortic and mitral valves. One of the most important differences is that the aortic annulus is relatively rigid and fixed while the mitral annulus is a more mobile structure."921 Splinting of the annulus with a rigid metal ring may, therefore, seriously interfere with left ventricular function. During systole the normal contraction geometry of the left ventricle may be distorted and during diastole the normal relaxation and active widening of a mitral orifice may be impaired; this can be expected to be particularly limiting at the high blood flow rates and short diastolic filling periods that occur during exercise. Finally, poor architectural siting of the valve may play an important role in the inadequate hemodynamic performance of these valves in many patients. Angiographic studies have shown the importance of valve alignment in relation to the geometric relationship of the inflow and outflow tracts of the ventricle in contributing to the adequacy of valve function.'5 Relatively small errors in alignment of the replaced valve may result in large changes in intraventricular flow patterns. Although it has been suggested that left ventricular performance may be abnormal in chronic rheumatic heart disease,22, 23 little quantitative information has been presented to support this clinical contention. But, whatever is finally concluded regarding the role of the myocardial factor in these patients, the abnormalities of left heart function engendered by these biological tissue valves are certainly of sufficient magnitude to account for the continued impairment of pumping activity of the heart so commonly observed when they are used for mitral valve replacement.
The introduction of this valve was a noteworthy surgical achievement and these clinical and hemodynamic results are the equal of those obtained with mechanical prostheses24-26 or other biological tissue valves.27 32 However, despite the potential advantages of this type of valve, these findings would suggest that its design and siting may still impose a significant hemodynamic penalty when the valve is used in the mitral orifice.
